Eleven Therapeutics is a biotechnology company at the forefront of the artificial intelligence revolution in medicinal nucleic acids. The new generation of RNAi therapies is introduced by merging artificial intelligence, parallel functional testing, and combinatorial chemistry. SCSI-RNA is a programmable molecule that can be used to target anydisease or biological target of interest.

Biotechnology

Health Care

Therapeutics

Eleven Therapeutics

Yaniv Erlich

Adi Gilboa-Geffen

Shaul Ilan

Roei Pinhas

Omer Weissbrod

Iris Grossman, PhD

The Research and Development team at Eleven Therapeutics is dedicated to pioneering the next generation of RNAi therapies through the integration of artificial intelligence, extensive functional testing, and avant-garde combinatorial chemistry. This diverse team of experts works collaboratively to innovate and optimize SCSI-RNA molecules, aiming to target a wide array of diseases and biological targets with precision and efficacy.

Research and Development

Leadership Team

Research and Development

About

Team members

Other teams at Eleven Therapeutics

Leadership Team